Search
IRX-2
go.drugbank.com/drugs/DB05643InvestigationalIRX-2 contains a human leukocyte-derived cytokine mixture. It is being investigated to promote or enhance an anti-cancer immune response.
Synonyms: Cytokine-based biologic agent IRX-2RAPA-501-Allo
go.drugbank.com/drugs/DB15890InvestigationalRAPA-501-ALLO is composed of T-cells extracted from healthy volunteers; these cells are then reprogrammed _ex vivo_ in a process that involves de-differentiation and re-differentiation.[L16483]
Silicon dioxide
go.drugbank.com/drugs/DB11132ApprovedColloidal silica is also used as a wine, beer, and juice fining agent or stabilizer. … Inhalation of fine crystals is toxic to humans leading to respiratory toxicity. In powdered food products and pharmaceutical tablets, silicon dioxide is added as a flow agent to absorb water.
Mixtures: E-Z-gas II, DOCTRUST ONE S ToothCategories: Compounds used in a research, industrial, or household settingRGX-121
go.drugbank.com/drugs/DB17681InvestigationalRGX-121 is designed to use the NAV AAV9 vector to deliver the human iduronate-2-sulfatase gene to the central nervous system.
Synonyms: Non-replicating recombinant adeno-associated virus (AAV) vector of serotype 9 expressing human iduronate-2-sulfataseZinc glycinate
go.drugbank.com/drugs/DB14493InvestigationalGlycoprotein marker of gastrointestinal cancer.
Synonyms: Zinc(II) glycinateMixtures: vitaMedMD Rx Plus, FeRiva 21 7Clenoliximab
go.drugbank.com/drugs/DB06241ExperimentalClenoliximab is a chimeric monoclonal antibody from _Macaca irus_ against CD4 which acts as an immunomodulator. It has investigated for the treatment of rheumatoid arthritis.
Ferrous asparto glycinate
go.drugbank.com/drugs/DB11169ApprovedFerrous asparto glycinate is an iron-amino acid chelate. It is available as a dietary supplement used in the treatment of iron deficiency and iron deficiency anemia.
Mixtures: Se-Vate 21/7, Integra FSaprisartan
go.drugbank.com/drugs/DB01347ExperimentalSaprisartan is an AT1 receptor antagonist. It is based on medications of losartan's prototypical chemical structure. … It is very likely that slow dissociation kinetics from the AT1 receptor underlie insurmountable antagonism [A14009].
Categories: Angiotensin II Type 1 Receptor Blockers, Heterocyclic Compounds, 2-RingPelacarsen
go.drugbank.com/drugs/DB16284InvestigationalPelacarsen is under investigation in clinical trial NCT03070782 (Phase 2 Study of ISIS 681257 (Akcea-apo(a)-lrx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease).
Synonyms: AKCEA-APO(a)-LRx, IONIS-APO(a)-LRxCD68-ET3-LV
go.drugbank.com/drugs/DB32864InvestigationalCD68-ET3-LV is an autologous gene therapy consisting of CD34+ hematopoietic stem and progenitor cells transduced ex-vivo with the CD68-ET3-LV lentiviral vector.